Business Context and Reporting Period
Company: InnovAge Holding Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 17, 2026
Reporting Period: The filing pertains to an upcoming investor event on March 17, 2026, and references the Company's full-year fiscal year 2026 guidance previously issued on February 3, 2026.
Key Financial Metrics
This filing does not contain specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. It serves as a notification of an upcoming presentation where the Company expects to reaffirm its previously issued full-year fiscal year 2026 guidance.
Material Changes
No material changes to financial results or operations are reported in this document. The filing confirms the Company's intention to maintain its existing full-year fiscal year 2026 guidance as announced in the February 3, 2026 press release.
Guidance, Outlook, and Management Commentary
- Event: The Company will meet with investors and analysts at the KeyBank Capital Markets Healthcare Forum on March 17, 2026.
- Guidance: Management expects to reaffirm its full-year fiscal year 2026 guidance.
- Reference: The guidance being reaffirmed was originally provided in the press release dated February 3, 2026, following the second fiscal quarter ended December 31, 2026.
- Materials: A presentation for the forum is available on the Company's Investor Relations website.
Investor Verification Checklist
- Verify the specific full-year fiscal year 2026 guidance figures in the press release dated February 3, 2026.
- Review the presentation materials posted on the InnovAge Investor Relations website for detailed operational updates.
- Confirm the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.